Vaccitech
1 known investors
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that direct T cells to address autoimmune and inflammatory diseases. Its work targets immunology and inflammatory (I&I) indications for patients.
Investors · 1
Frequently asked questions
- What does Vaccitech do?
- Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that direct T cells to address autoimmune and inflammatory diseases. Its work targets immunology and inflammatory (I&I) indications for patients.
- Who are Vaccitech's investors?
- Vaccitech's investors include Future Planet Capital.